You are here

  • Home
  • Online First
  • Implications of LAG3 and CTLA4 immune checkpoints beyond PD-1/PD-L1 as a potential target in determining the prognosis of uveal melanoma patients

Article info

Article menu
Download PDFPDF
Laboratory science
Implications of LAG3 and CTLA4 immune checkpoints beyond PD-1/PD-L1 as a potential target in determining the prognosis of uveal melanoma patients

Authors

  1. Correspondence to Dr. Lata Singh, Pediatrics, All India Institute of Medical Sciences, New Delhi, India; lata.aiims{at}gmail.com; Dr. Mithalesh Kumar Singh; mithales{at}hs.uci.edu; mithalesh.aiims{at}gmail.com
View Full Text

Citation

Kashyap S, Singh MK, Kumar N, et al
Implications of LAG3 and CTLA4 immune checkpoints beyond PD-1/PD-L1 as a potential target in determining the prognosis of uveal melanoma patients
British Journal of Ophthalmology Published Online First: 14 March 2023. doi: 10.1136/bjo-2022-322913

Publication history

  • Received November 24, 2022
  • Accepted February 24, 2023
  • First published March 14, 2023.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.